|
ELF1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.425970E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.987200E-01 |
| Normal-vs-Stage2 |
8.948400E-01 |
| Normal-vs-Stage3 |
6.776500E-03 |
| Normal-vs-Stage4 |
1.136290E-02 |
| Stage1-vs-Stage2 |
5.971800E-01 |
| Stage1-vs-Stage3 |
1.664250E-03 |
| Stage1-vs-Stage4 |
5.359700E-03 |
| Stage2-vs-Stage3 |
2.772100E-02 |
| Stage2-vs-Stage4 |
3.307600E-02 |
| Stage3-vs-Stage4 |
9.741400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.656780E-01 |
| Normal-vs-AfricanAmerican |
6.001800E-02 |
| Normal-vs-Asian |
7.040200E-01 |
| Caucasian-vs-AfricanAmerican |
2.333400E-01 |
| Caucasian-vs-Asian |
3.745400E-01 |
| AfricanAmerican-vs-Asian |
2.294200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.648830E-01 |
| Normal-vs-Female |
1.660640E-01 |
| Male-vs-Female |
9.893600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.749400E-01 |
| Normal-vs-Age(41-60Yrs) |
5.165200E-01 |
| Normal-vs-Age(61-80Yrs) |
6.303700E-02 |
| Normal-vs-Age(81-100Yrs) |
1.676310E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.205200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.923200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.678000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.579900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.409600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.376150E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.889610E-01 |
| Normal-vs-Grade 2 |
9.056600E-01 |
| Normal-vs-Grade 3 |
1.793740E-02 |
| Normal-vs-Grade 4 |
4.817600E-03 |
| Grade 1-vs-Grade 2 |
1.816430E-01 |
| Grade 1-vs-Grade 3 |
6.455100E-03 |
| Grade 1-vs-Grade 4 |
4.162900E-03 |
| Grade 2-vs-Grade 3 |
2.699900E-03 |
| Grade 2-vs-Grade 4 |
1.163380E-03 |
| Grade 3-vs-Grade 4 |
1.613560E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.802400E-01 |
| Normal-vs-ccB subtype |
8.485700E-02 |
| ccA subtype-vs-ccB subtype |
5.158200E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.184000E-01 |
| Normal-vs-N1 |
2.691000E-01 |
| N0-vs-N1 |
6.185200E-01 |
|
|
